A patient treated for a urinary tract infection 2–3 weeks ago with levofloxacin 750 mg daily for 5 days now presents with dysuria and urinary frequency that began yesterday; what is the appropriate next step in management?

Obtain Urine Culture and Initiate Empirical Antibiotic Therapy

This patient requires immediate urine culture with susceptibility testing followed by empirical antibiotic treatment for presumed recurrent UTI, avoiding fluoroquinolones given recent levofloxacin exposure.

Diagnostic Approach

The presentation of dysuria and urinary frequency one day after onset, occurring 2-3 weeks after completing levofloxacin therapy, represents either:

• Treatment failure with fluoroquinolone-resistant organism
• Reinfection with a new pathogen
• Relapse from inadequately treated infection

Obtain urine culture with susceptibility testing before initiating antibiotics 1. This is critical because:

• Recent fluoroquinolone exposure increases risk of resistant organisms 2, 3
• Empirical therapy must be tailored based on local resistance patterns
• Fluoroquinolone resistance rates have increased substantially, limiting their utility 3, 4

Important Diagnostic Pitfall

Be aware that fluoroquinolones can suppress bacterial growth in urine cultures for up to 10 days after discontinuation, particularly in elderly or diabetic patients 2. If initial culture is negative but symptoms persist, repeat culture 7-10 days later may be necessary.

Empirical Treatment Selection

For Uncomplicated Cystitis (Lower Tract Symptoms Only)

First-line options 1, 5:

1. Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days (preferred given recent fluoroquinolone use)
2. Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local resistance <20%)
3. Fosfomycin 3 g single dose (alternative with slightly lower efficacy)

Avoid fluoroquinolones (ciprofloxacin, levofloxacin) as they should be reserved for important uses and the patient just received levofloxacin 1.

For Pyelonephritis (If Fever, Flank Pain, or Systemic Symptoms Present)

If the patient has fever, costovertebral angle tenderness, or appears systemically ill 6:

Outpatient oral therapy options 6:

• Cefpodoxime 200 mg twice daily for 10 days, OR
• Ceftibuten 400 mg daily for 10 days
• Consider initial IV dose of ceftriaxone 1-2 g before starting oral therapy

Avoid fluoroquinolones empirically given recent exposure and unknown resistance patterns 6.

Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days is acceptable only if susceptibility is confirmed 6, 1.

Critical Management Points

Why Not Repeat Levofloxacin?

The patient received levofloxacin 750 mg daily for 5 days just 2-3 weeks ago 7. Repeating the same fluoroquinolone is inappropriate because:

• High probability of fluoroquinolone-resistant organism if this represents treatment failure 1, 3, 4
• Fluoroquinolones have "propensity for collateral damage" and should be reserved for important uses 1
• Rising fluoroquinolone resistance rates (often >10% in many communities) limit empirical use 6, 3

Assess for Complicating Factors

Evaluate for factors suggesting complicated UTI 6:

• Structural/functional urinary tract abnormalities
• Immunosuppression or diabetes
• Recent instrumentation
• Male gender
• Pregnancy

If complicating factors present, longer treatment duration and broader coverage may be needed 6.

Follow-Up Strategy

1. Tailor therapy based on culture results when available (48-72 hours) 1
2. If symptoms persist after 48-72 hours on appropriate therapy, consider:
   • Imaging (renal ultrasound) to exclude obstruction or abscess 6
   • Repeat urine culture if initial was negative (may have been suppressed by recent antibiotics) 2
3. Clinical improvement expected within 48-72 hours for cystitis, longer for pyelonephritis 1

Key Takeaway

Start nitrofurantoin 100 mg twice daily for 5 days for presumed uncomplicated cystitis after obtaining urine culture. Escalate to cephalosporin therapy if pyelonephritis suspected. Avoid repeating fluoroquinolones given recent exposure and high risk of resistance.